May 06, 2026 9:00am EDT NEXGEL Appoints Brian Kieser and Kevin Harris from New Strategic Partner, Sequence LifeScience™, to Board of Directors
Apr 21, 2026 9:00am EDT NEXGEL New Strategic Partner, Sequence LifeScience™, Leads Financing with $5.5 Million to Complete Acquisition of Celularity Degenerative Disease Segment
Apr 17, 2026 3:37pm EDT NEXGEL Moves Forward Shareholder Update Call to Discuss Celularity Transaction on April 21st at 4:30 P.M. ET
Apr 15, 2026 4:12pm EDT NEXGEL Reschedules Shareholder Update Conference Call to April 23rd at 4:30 P.M. ET to Provide Update on Celularity Transaction
Apr 08, 2026 4:05pm EDT NEXGEL Reschedules Shareholder Update Conference Call to April 15th at 4:30 P.M. ET to Provide Update on Celularity Transaction
Mar 31, 2026 4:12pm EDT NEXGEL Reschedules 2025 Financial Results Conference Call to April 8th at 4:30 P.M. ET to Provide Shareholders with an Update on Its Previously Announced Transaction with Celularity
Mar 25, 2026 9:00am EDT NEXGEL to Report Fourth Quarter and Full Year 2025 Financial Results on March 31st
